Lymphoma, Hodgkin: Clinical Trials

15 trials for Lymphoma, Hodgkin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 unknown, 3 recruiting, 2 active not recruiting. 7 Not applicable, 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable7Terminated 2, Unknown 2, Active not recruiting 1, Completed 1, Recruiting 1
Phase 13Active not recruiting 1, Completed 1, Unknown 1
Phase 22Recruiting 1, Unknown 1

Follow Lymphoma, Hodgkin: new trials by email Literature Review of Lymphoma, Hodgkin trials Research Report on Lymphoma, Hodgkin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial
Interrupted Sedentary Time Intervention - Lymphoma, Lymphoma, Hodgkin
Not applicableRecruitingDana-Farber Cancer Institute242025-06-052026-04-13
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
Miltenyi CliniMACS Prodigy ® system - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2RecruitingUniversity of Florida202024-05-032026-06-04
Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours
Ocoxin Oral solution - Advanced Cancer, Advanced Solid Tumor
Not applicableUnknownCatalysis SL402024-04-282024-04-12
STAY-STRONG Study of Exercise Training During Chemotherapy
Resistance Exercise Training - Lymphoma, B-Cell, Lymphoma, Hodgkin
Not applicableCompletedCopenhagen University Hospital, Rigshospitalet422022-10-252025-12-08
A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
Pharmacokinetics - Lymphoma, Lymphoma, B-Cell
Phase 1Active not recruitingMemorial Sloan Kettering Cancer Center392022-09-092026-03-06
Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG
Intervention - Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin
Not applicableActive not recruitingAssistance Publique - Hôpitaux de Paris1282022-04-012025-08-13
Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of Lymphoma
Myo-Inositol and D-Chiro-Inositol (MIC) - Lymphoma, Hodgkin, Menstrual Irregularity
CompletedUniversity of Bari Aldo Moro902020-02-072022-06-08
Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma
OT-82 Dose Escalation, OT-82 Dose Expansion - Lymphoma, Lymphoma, Non-Hodgkin
Phase 1UnknownOncotartis, Inc.502019-07-292020-10-23
Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response
MOOVCARE - Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse
Not applicableTerminatedWeprom522017-07-122021-04-28
Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation
Plerixafor 0.12 mg/kg - Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin
Phase 2UnknownHospital Universitario Dr. Jose E. Gonzalez202017-05-102017-08-10
Precision Exercise in Children With Malignant Hemopathies
Sport Therapy - Leukemia, Myeloid, Acute, Leukemia, B-cell
Not applicableUnknownUniversity of Milano Bicocca3802017-04-032024-01-02
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
Chemotherapy - Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin
RecruitingSamsung Medical Center6002017-03-012025-05-21
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
Bendamustine, Cyclophosphamide - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia
Phase 1CompletedUniversity of Arizona502016-11-292025-11-10
MELT - MRI Evaluation of Lymphoma Treatment
Lymphoma, Hodgkin
CompletedUniversity College, London582011-09-012015-12-03
T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE
Ara C, Mesna, Cyclophosphamide - Leukemia, Cancer
Not applicableTerminatedBaylor College of Medicine262007-10-012016-04-22

Narrower conditions

Hodgkin Disease (15)  ·  Lymphoma, Non-Hodgkin (10)  ·  Lymphoma (9)  ·  Leukemia (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Lymphoma, B-Cell (3)  ·  Lymphoma, T-Cell (3)  ·  Neoplasms (3)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2)  ·  Lymphoma, Follicular (2)  ·  Motor Activity (2)  ·  Myelodysplastic Syndromes (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Adrenoleukodystrophy (1)  ·  Burkitt Lymphoma (1)

Broader conditions

Hemic and Lymphatic Diseases (15)  ·  Immune System Diseases (15)  ·  Immunoproliferative Disorders (15)  ·  Lymphatic Diseases (15)  ·  Lymphoproliferative Disorders (15)  ·  Neoplasms by Histologic Type (15)  ·  Neoplasms (12)  ·  Lymphoma (6)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Hematologic Diseases (4)  ·  Pathologic Processes (4)  ·  Behavior (3)  ·  Bone Marrow Diseases (3)  ·  Leukemia, Lymphoid (3)  ·  Leukemia, Myeloid (3)

Interventions

Cyclophosphamide (2)  ·  Bendamustine Hydrochloride (1)  ·  Cytarabine (1)  ·  Drug Therapy (1)  ·  Inositol (1)  ·  Mesna (1)  ·  Methods (1)  ·  Ocoxin (1)  ·  Pharmacokinetics (1)  ·  Resistance Training (1)  ·  Therapeutics (1)  ·  plerixafor (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Baylor College of Medicine (1)  ·  Catalysis SL (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Dana-Farber Cancer Institute (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Oncotartis, Inc. (1)  ·  Samsung Medical Center (1)  ·  University College, London (1)  ·  University of Arizona (1)  ·  University of Bari Aldo Moro (1)  ·  University of Florida (1)  ·  University of Milano Bicocca (1)  ·  Weprom (1)

Countries

United States (6)  ·  France (2)  ·  Italy (2)  ·  Denmark (1)  ·  Honduras (1)  ·  Mexico (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Andrea Biondi, MD, PhD (1)  ·  Christina Dieli-Conwright, MD, PhD (1)  ·  David Gomez Almaguer, md (1)  ·  Emmanuel Katsanis, MD (1)  ·  Eric Rowinsky, MD (1)  ·  Jordan Milner, MD (1)  ·  Katell LE DU, MD (1)  ·  Parastoo Dahi, MD (1)  ·  Robert Krance, MD (1)  ·  Seok Jin Kim, MD, PhD (1)  ·  Stuart A Taylor, Prof (1)

Results publications

PMID 19720922, PMID 20067838, PMID 20530974, PMID 28067870, PMID 29908231, PMID 31618456, PMID 32582591, PMID 35460929, PMID 35847727, PMID 39606939, PMID 40270968